Skip to main content
Veterinary Medicines

Proin 15 mg chewable tablets for dogs

Authorised
  • Phenylpropanolamine hydrochloride

Product identification

Medicine name:
Proin 15 mg chewable tablets for dogs
PROIN 15 COMPRIME A CROQUER POUR CHIENS
Active substance:
  • Phenylpropanolamine hydrochloride
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Phenylpropanolamine hydrochloride
    15.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG04BX91
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • White high density polyethylene bottles containing a 5 gram desiccant pack and cotton, sealed with a child resistant, foil lined heat sealed white polypropylene cap. Pack size: 60 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Pegasus Laboratories Ireland Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Tairgi Tread-Lia Baile Na Sceilge Teoranta Limited
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/8395098 4/2017
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0361/001
Concerned member states:
  • Belgium
  • France
  • Germany
  • Italy
  • Netherlands
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
French (PDF)
Published on: 25/01/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."